Pacific Edge Limited
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic produc… Read more
Market Cap & Net Worth: Pacific Edge Limited (PFGTF)
Pacific Edge Limited (PINK:PFGTF) has a market capitalization of $80.76 Million ($80.76 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #19746 globally and #7233 in its home market, demonstrating a -28.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pacific Edge Limited's stock price $0.08 by its total outstanding shares 1022325779 (1.02 Billion).
Pacific Edge Limited Market Cap History: 2016 to 2025
Pacific Edge Limited's market capitalization history from 2016 to 2025. Data shows change from $373.15 Million to $80.76 Million (-18.66% CAGR).
Pacific Edge Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pacific Edge Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.70x
Pacific Edge Limited's market cap is 3.70 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $373.15 Million | $4.98 Million | -$15.68 Million | 75.00x | N/A |
| 2017 | $204.47 Million | $2.24 Million | -$15.79 Million | 91.18x | N/A |
| 2018 | $214.69 Million | $3.40 Million | -$19.64 Million | 63.14x | N/A |
| 2019 | $122.68 Million | $3.82 Million | -$17.92 Million | 32.14x | N/A |
| 2020 | $797.41 Million | $4.37 Million | -$18.89 Million | 182.47x | N/A |
| 2021 | $1.23 Billion | $2.15 Million | -$14.22 Million | 570.07x | N/A |
| 2022 | $282.47 Million | $11.45 Million | -$19.79 Million | 24.68x | N/A |
| 2023 | $70.34 Million | $19.62 Million | -$26.96 Million | 3.59x | N/A |
| 2024 | $93.95 Million | $26.06 Million | -$29.54 Million | 3.60x | N/A |
| 2025 | $80.76 Million | $21.85 Million | -$29.94 Million | 3.70x | N/A |
Competitor Companies of PFGTF by Market Capitalization
Companies near Pacific Edge Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Pacific Edge Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Pacific Edge Limited Historical Marketcap From 2016 to 2025
Between 2016 and today, Pacific Edge Limited's market cap moved from $373.15 Million to $ 80.76 Million, with a yearly change of -18.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $80.76 Million | -14.04% |
| 2024 | $93.95 Million | +33.58% |
| 2023 | $70.34 Million | -75.10% |
| 2022 | $282.47 Million | -76.97% |
| 2021 | $1.23 Billion | +53.85% |
| 2020 | $797.41 Million | +550.00% |
| 2019 | $122.68 Million | -42.86% |
| 2018 | $214.69 Million | +5.00% |
| 2017 | $204.47 Million | -45.21% |
| 2016 | $373.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pacific Edge Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $80.76 Million USD |
| MoneyControl | $80.76 Million USD |
| MarketWatch | $80.76 Million USD |
| marketcap.company | $80.76 Million USD |
| Reuters | $80.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.